Leukemia, Lymphoma, and Myeloma Awareness Month.
By officially declaring September as Awareness Month for leukemia, lymphoma, and myeloma, the bill aims to encourage participation in activities that support research funding and educational initiatives. This resolution aligns the state with organizations, such as the Leukemia & Lymphoma Society, which actively work to find cures and provide support to patients and their families. The state's commitment to these efforts aims to foster an environment conducive to advancing research in treatment and eradication of blood cancers.
ACR166, introduced by Assembly Member Fong, seeks to designate the month of September 2020 as Leukemia, Lymphoma, and Myeloma Awareness Month. The resolution aims to enhance public understanding of blood-related cancers, which currently affect over 1.3 million Americans with a significant annual mortality rate. It emphasizes the necessity for increased awareness and education surrounding these grave diseases.
While the resolution does not impose regulatory burdens or direct legislative action, it signifies a broader awareness effort connected with healthcare initiatives. The bill underscores the importance of community involvement and state support in fighting cancer, though it may also lead to discussions on the adequacy of current healthcare provisions and resources dedicated to cancer research and patient assistance.